Additionally, mesenchymal human GBM tissue has been observed to produce a widespread signal of WNT5A immunoreactivity upon IHC analyses, whereas proneural and classical tissue samples only had a few WNT5A-positive cells [58]. The gene discussed is WNT5A; the disease is glioblastoma.